How much is Resilient Biotics worth in 2026?

Resilient Biotics has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Resilient Biotics raised?

Resilient Biotics has raised N/A in total funding across 1 funding rounds.

Resilient Biotics

Drug Discovery

Resilient Biotics valuation and funding history | Last updated: December 9, 2020 | 1 funding rounds

Current Valuation

N/A

As of December 9, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$7.2M

Last Funding

Dec 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 9, 2020	Early Stage VC (Series A)	$7.2M	N/A	-

Valuation Analysis

Current Valuation Metrics

Resilient Biotics is currently valued at N/A as of December 9, 2020.

Track Resilient Biotics Valuation Updates

Get notified when Resilient Biotics raises new funding or valuation changes

Explore More Data

Detailed analysis for Resilient Biotics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Resilient Biotics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Resilient Biotics Worth in 2026?

Resilient Biotics is a leading private company in the Drug Discovery sector. Track Resilient Biotics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Resilient Biotics Valuation is Determined

Private company valuations like Resilient Biotics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.